BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30817743)

  • 21. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.
    Yu G; Yu W; Jin G; Xu D; Chen Y; Xia T; Yu A; Fang W; Zhang X; Li Z; Xie K
    Mol Cancer; 2015 Nov; 14():193. PubMed ID: 26576639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcineurin/NFATc1 pathway contributes to cell proliferation in hepatocellular carcinoma.
    Wang S; Kang X; Cao S; Cheng H; Wang D; Geng J
    Dig Dis Sci; 2012 Dec; 57(12):3184-8. PubMed ID: 22722879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Silencing pyruvate kinase M2 sensitizes human prostate cancer PC3 cells to gambogic acid-induced apoptosis].
    Lü L; Wang L; Jiang GS; Zhang CH; Zeng FQ
    Zhonghua Nan Ke Xue; 2013 Feb; 19(2):102-6. PubMed ID: 23441447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
    Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
    Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation.
    Wang W; Wang J
    Med Sci Monit; 2018 Aug; 24():5588-5597. PubMed ID: 30098292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer.
    Mitsunari K; Miyata Y; Asai A; Matsuo T; Shida Y; Hakariya T; Sakai H
    Transl Res; 2016 Sep; 175():116-28. PubMed ID: 27140699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of zinc finger protein 403 on the proliferation, migration and invasion abilities of prostate cancer cells.
    Xu X; Zhu Z; Xu Y; Tian S; Jiang Y; Zhao H
    Oncol Rep; 2020 Dec; 44(6):2455-2464. PubMed ID: 33125130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis.
    Yi C; Wan X; Zhang Y; Fu F; Zhao C; Qin R; Wu H; Li Y; Huang Y
    Int J Biochem Cell Biol; 2018 Sep; 102():138-150. PubMed ID: 30053504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2.
    Wang X; Xu Y; Wang X; Jiang C; Han S; Dong K; Shen M; Xu D
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28994148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA‑195‑5p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1.
    Chen B; Bai G; Ma X; Tan L; Xu H
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
    Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
    Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
    Feng J; Ma T; Ge Z; Lin J; Ding W; Chen H; Zhu W; Zhou S; Tan Y
    Mol Med Rep; 2015 Mar; 11(3):2111-7. PubMed ID: 25411978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.
    Chen Y; Tian Y; Ji Z; Liu Z; Shang D
    Tumour Biol; 2015 Jul; 36(7):5537-41. PubMed ID: 25682287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [MiR-124 suppresses the proliferation of human prostate cancer PC3 cells by targeting PKM2].
    Lü L; Yuan JD; Cao ZL; Huang T; Zhang CH; Wang L; Zeng FQ
    Zhonghua Nan Ke Xue; 2014 Jun; 20(6):495-9. PubMed ID: 25029852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
    Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
    Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.